Form 4 for PTGX Protagonist Therapeutics, Inc
Accepted 2024-07-26 00:00:00 ET · period of report 2024-07-24 · accession 0001104659-24-083039 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-07-26 | 2024-07-24 | PTGX | Waddill William D. | Dir | S - Sale+OE | $40.00 | -8,000 | 12.0K | -40% | -$320.0K |
| D | 2024-07-26 | 2024-07-24 | PTGX | Waddill William D. | Dir | M - OptEx | $12.88 | +8,000 | 20.0K | +67% | +$103.0K |
| D | 2024-07-26 | 2024-07-24 | PTGX | Waddill William D. | Dir | M - OptEx | $0.00 | -8,000 | 8,000 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-24 | S | D | 8,000 | $40.00 | 12,000 | D | — | — | |
| 2 | Common | Common Stock | 2024-07-24 | M | A | 8,000 | $12.88 | 20,000 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2024-07-24 | M | D | 8,000 | $0.00 | 8,000 | D | $12.88 · — to 2026-09-13 | 8,000 Common Stock | (F2) These stock options are fully vested. |